Patents by Inventor Robert Leon Sharp

Robert Leon Sharp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Excitatory amino acid receptor protein and related nucleic acid compounds
    Patent number: 6387655
    Abstract: This invention describes a novel human glutamate receptors, designated HmGluR3. This invention also encompasses nucleic acids encoding this receptor, or a fragment thereof, as well as methods employing this receptor and the nucleic acid compounds.
    Type: Grant
    Filed: December 19, 1996
    Date of Patent: May 14, 2002
    Assignee: Eli Lilly and Company
    Inventors: J. Paul Burnett, Jr., Nancy Gail Mayne, Robert Leon Sharp
  • Isolated nucleic acid encoding a human mGluR5
    Patent number: 6211353
    Abstract: This invention describes two novel human glutamate receptors, designated mGluR5A and mGluR5B. This invention also encompasses nucleic acids encoding this receptor, or a fragment thereof, as well as methods employing this receptor and the nucleic acid compounds.
    Type: Grant
    Filed: June 7, 1996
    Date of Patent: April 3, 2001
    Assignee: Eli Lilly and Company
    Inventors: James Paul Burnett, Jr., Nancy Gail Mayne, Robert Leon Sharp, Yvonne Marie Snyder
  • Excitatory amino acid receptor protein expression testing methods
    Patent number: 6103475
    Abstract: This invention describes a novel human glutamate receptors, designated mGluR2. This invention also encompasses nucleic acids encoding this receptor, or a fragment thereof, as well as methods employing this receptor and the nucleic acid compounds.
    Type: Grant
    Filed: February 26, 1999
    Date of Patent: August 15, 2000
    Assignee: Eli Lilly and Company
    Inventors: James Paul Burnett, Jr., Nancy Gail Mayne, Robert Leon Sharp, Yvonne Marie Snyder
  • Excitatory amino acid receptor protein and related nucleic acid compounds
    Patent number: 6017697
    Abstract: This invention describes a novel human glutamate receptors, designated mGluR2. This invention also encompasses nucleic acids encoding this receptor, or a fragment thereof, as well as methods employing this receptor and the nucleic acid compounds.
    Type: Grant
    Filed: November 14, 1994
    Date of Patent: January 25, 2000
    Assignee: Eli Lilly and Company
    Inventors: James Paul Burnett, Jr., Nancy Gail Mayne, Robert Leon Sharp, Yvonne Marie Snyder